Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control

BACKGROUND: The prognostic benefits of beta-blockers (BB) in patients with systolic heart failure (SHF) are known but despite this, in patients with diabetes they are underutilized. The aim of this study was to assess the effect of beta-blockers (BB) on glycaemic control in patients with Type 2 Diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wai, Bryan, Kearney, Leighton G, Hare, David L, Ord, Michelle, Burrell, Louise M, Srivastava, Piyush M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298480/
https://www.ncbi.nlm.nih.gov/pubmed/22330091
http://dx.doi.org/10.1186/1475-2840-11-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298480/
https://www.ncbi.nlm.nih.gov/pubmed/22330091
http://dx.doi.org/10.1186/1475-2840-11-14

Ejemplares similares